|
Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis Clinical research trials and Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis. Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis clinical trial. Participants frequently obtain the most expert healthcare available for their Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis
Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis
For Condition: Multiple Sclerosis
Status: No longer recruiting
Sponsor(s): Biogen Idec , Elan Pharmaceuticals
Synopsis: The purpose of this study is to determine if natalizumab in combination with AVONEX is safe and effective in delaying progression of individuals diagnosed with relapsing remitting MS.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/50 Years
Genders: Both
Protocol Entry Criteria: Male and female subjects between 18 and 50 years of age who have a diagnosis of relapsing remitting multiple sclerosis and who have been treated with Avonex for at least 12 months prior to study entry.
Total Enrollment:
Location and Contact Information:
University Hospital at Stony Brook
Stony Brook, New York, 11794
United States
LSU Neurolgoy Clinic in New Orleans
New Orleans, Louisiana, 70112
United States
University of Pittsburgh, Department of Neurology
Pittsburgh, Pennsylvania, 15213
United States
Healthsouth Rehabilitation Hospital
Colorado Springs, Colorado, 80910
United States
North Ridge NeuroScience Center
Ft. Lauderdale, Florida, 33334
United States
Kaiser-Permanente Medical Center
Redwood City, California, 94063
United States
Hopital Universitaire U.L.B. Erasme
Brussels, , 1780
Belgium
Universitaetsklinikum Giessen, Oberarzt Neurologie
Giessen, , 35390
Germany
Buffalo General Hospital, Department of Neurology
Buffalo, New York, 14203
United States
Marietta Neurological Associates
Marietta, Georgia, 30060
United States
Allegheny Singer Research Institute
Pittsburgh, Pennsylvania, 15212
United States
Northwestern University, Department of Neurology
Chicago, Illinois, 60611
United States
Griffin Hospital
Derby, Connecticut, 06418
United States
St. Luke's Roosevelt Hospital, MS Research & Treatment Center
New York City, New York, 10019
United States
Greenstein Neurology Associates & MS Institute
Philadelphia, Pennsylvania, 19146
United States
Michigan Institute for Neurological Disorders
Farmington Hills, Michigan, 48334
United States
Indiana University Medical Center
Indianapolis, Indiana, 46202
United States
Maimonides Medical Center, Division of Neurology
Brooklyn, New York, 11219
United States
MS Center at Carolinas Medical Center
Charlotte, North Carolina, 28232-2861
United States
Noran Neurological Clinic
Minneapolis, Minnesota, 55404
United States
Albany Medical Center
Albany, New York, 12208
United States
UTSW Medical School
Dallas, Texas, 75235-9036
United States
Providence Saint Vincent Medical Center
Portland, Oregon, 97225
United States
University of Arkansas For Medical Sciences
Little Rock, Arkansas, 72205
United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
United States
Henry Ford Hospital
Detroit, Michigan, 48202-2608
United States
St. John's Mercy Medical Center
St. Louis, Missouri, 63141
United States
New York Hospital - Cornell Medical Center
New York City, New York, 10021
United States
Springfield Clinic Neuroscience Institute
Springfield, Illinois, 62702
United States
Bernard W. Gimbel MS Center
Teaneck, New Jersey, 07666
United States
Fachbereich Neurologie und Klinische Neurophysiologie
Wiesbaden, , 65191
Germany
Staten Island University Hospital
Staten Island, New York, 10305
United States
University of Alabama-Birmingham, Department of Neurology
Birmingham, Alabama, 35233
United States
Elisabeth Ziekenhuis
Sijsele, , 8340
Belgium
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655-0138
United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
Mercy Hospital Outpatient Pharmacy
Des Moines, Iowa, 50314
United States
Consultants in Neurology Northbrook
Northbrook, Illinois, 60062
United States
Michigan State University MS Clinic
East Lansing, Michigan, 48824
United States
Alexian Brothers Center for Clinical Research
Elk Grove Village, Illinois, 60007
United States
Hadassah Hebrew Uni Hospital, Department of Neurology
Jerusalem, ,
Israel
MS Center at UCSF
San Francisco, California, 94117
United States
Virginia Mason Medical Center
Seattle, Washington, 98111
United States
Neurologische Abteilung
Henningsdorf, , 16761
Germany
Universita di Genova, Clinica Neurologica
Genova, , 16132
Italy
MS Care Center
New York City, New York, 10003
United States
Loyola Medical Center
Maywood, Illinois, 60153
United States
Judisches Krankenhaus
Berlin, , 13347
Germany
Maine Neurology
Scarborough, Maine, 04074-8926
United States
Geisinger Medical Center
Danville, Pennsylvania, 17822
United States
Phoenix Neurological Associates, Ltd.
Phoenix, Arizona, 85008
United States
University of California - Irvine
Irvine, California, 92697
United States
Vanderbilt Medical Center
Nashville, Tennessee, 37215
United States
Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States
University of Maryland Hospital, Department of Neurology
Baltimore, Maryland, 21201
United States
SUNY Upstate Medical University
Syracuse, New York, 13210
United States
University of Miami, Department of Neurology
Miami, Florida, 33136
United States
University of Virginia Health Sciences
Charlottesville, Virginia, 22908
United States
Upstate Clinical Research, LLC
Albany, New York, 12205
United States
University of Colorado MS Center
Denver, Colorado, 80262
United States
Hopital neurologique Pierre Werth
Lyon, , 69394
France
Baylor Methodist International MS Center
Houston, Texas, 77030
United States
MS Research Center
Seattle, Washington, 98195
United States
USC MS Comprehensive Care Center
Los Angeles, California, 90033
United States
Wake Forest University School of Medicine, Department of Neurology
Winston Salem, North Carolina, 27157
United States
Option Care Infusion
Dallas, Texas, 75226
United States
Universitatsklinik fur Neurologie
Innsbruck, , 6020
Austria
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505
United States
New York State Psychiatric Institution
New York City, New York, 10032
United States
The Multiple Sclerosis Center of Atlanta
Atlanta, Georgia, 30327
United States
Rush-Presbyterian St. Luke's Medical Center
Chicago, Illinois, 60612
United States
Riverhills Neurology
Cincinnati, Ohio, 45219
United States
Fletcher Allen Health Care
Burlington, Vermont, 05401
United States
Strong Health Pharmacy Services
Rochester, New York, 14642
United States
Asklepios Klinik Schildautal
Seesen/Harz, , 38723
Germany
George Washington University MS Center
Washington D.C., District of Columbia, 20037
United States
Sheba Medical Center, MS Center
Tel Hashomer, , 52621
Israel
Universitatsklinik fur Neurologie
Graz, , 8036
Austria
Central Texas Neurology
Round Rock, Texas, 78681
United States
Hopital Pellegrin Tripode, Neurologie
Bordeaux, , 33076
France
Medizinische Hochschule Hannover, Neurologische Klinik
Hannover, , 30625
Germany
Maitland Neurology
Maitland, Florida, 32751
United States
Neurological Associates, Inc.
Richmond, Virginia, 23226
United States
St. Francis Hospital, Center for Neurological Disorders
Milwaukee, Wisconsin, 53215
United States
University of Tennessee - Memphis
Memphis, Tennessee, 38163
United States
Städtische Kliniken Osnabrück
Osnabrück, , 49076
Germany
Raleigh Neurology Associates
Raleigh, North Carolina, 27607
United States
Georgetown Univesity Hospital, Research Pharmacy
Washington D.C., District of Columbia, 20007
United States
Additional Information:
Study ID Numbers: C-1802;
Study Start Date: January 2002
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00030966
Other Multiple Sclerosis Studies:
1. High dose chemo/radiotherapy and hematopoietic stem cell transplant for patients with multiple sclerosis.
2. Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis
3. Safety of RG2077 in Patients With Multiple Sclerosis
4. Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis
5. Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS)
Related Studies:
Other Multiple Sclerosis Clinical Trials
Other New Jersey Clinical Trials
Other Teaneck Clinical Trials
Safety and Efficacy of Natalizumab in Combination with Avonex in the Treatment of Multiple Sclerosis
|
|
|
|
|
|
|
|